Soleus Capital

Soleus Capital

Overview

Soleus Capital is a healthcare investment firm located in Greenwich, CT which manages hedge, private equity and credit funds primarily focused on the innovative areas of life sciences, including biotech, medtech, diagnostics, and genomics . The firm invests across the healthcare lifecycle from developmental-stage companies through commercial companies . Soleus Capital's primary investment strategy seeks superior risk-adjusted returns over time by investing in the healthcare sector .

Year Founded

2018

Portfolio Companies

34

Investments

CompanyDateStageLead
Candid TherapeuticsMar 2026PIPECo-investor
Parabilis MedicinesJan 2026Series FCo-investor
Longeviti Neuro SolutionsAug 2025StrategicLead
Pillar BiosciencesMay 2025StrategicCo-investor
Neurona TherapeuticsApr 2025Early Funding-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

Headquarters
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.